Open Access

[Corrigendum] Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer

  • Authors:
    • Bo Yin
    • Mo Zhang
    • Yu Zeng
    • Youqiang Li
    • Chao Zhang
    • Yongsheng Song
  • View Affiliations

  • Published online on: May 30, 2016     https://doi.org/10.3892/ijo.2016.3545
  • Pages: 848-848
  • Copyright: © Yin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Downregulation of cytokeratin 18 is associated with paclitaxel-resistance and tumor aggressiveness in prostate cancer

BO YIN, MO ZHANG, YU ZENG, YOUQIANG LI, CHAO ZHANG, YONGSHENG SONG

[Related article:] Int J Oncol 48: 1730–1736, 2016; DOI: 10.3892/ijo.2016.3396

After the publication of the article, the authors noted that they would like to add Dr Robert H. Getzenberg's name to the authors' list and as a co-corresponding author, upon the agreement of all the authors. The correct author list should be as follows:

BO YIN1, MO ZHANG1, YU ZENG2,3*, YOUQIANG LI3, CHAO ZHANG1, ROBERT H. GETZENBERG3* and YONGSHENG SONG1*

1Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004; 2Department of Urology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China; 3James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21087, USA

Correspondence should now be addressed to: Correspondence to: Dr Yongsheng Song, Department of Urology, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang, Liaoning 110004, P.R. China, E-mail: yinbowzf@163.com

Dr Robert H. Getzenberg, James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21087, USA, E-mail: getzenberg@outlook.com

*Contributed equally

Related Articles

Journal Cover

August-2016
Volume 49 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yin B, Zhang M, Zeng Y, Li Y, Zhang C and Song Y: [Corrigendum] Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer. Int J Oncol 49: 848-848, 2016.
APA
Yin, B., Zhang, M., Zeng, Y., Li, Y., Zhang, C., & Song, Y. (2016). [Corrigendum] Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer. International Journal of Oncology, 49, 848-848. https://doi.org/10.3892/ijo.2016.3545
MLA
Yin, B., Zhang, M., Zeng, Y., Li, Y., Zhang, C., Song, Y."[Corrigendum] Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer". International Journal of Oncology 49.2 (2016): 848-848.
Chicago
Yin, B., Zhang, M., Zeng, Y., Li, Y., Zhang, C., Song, Y."[Corrigendum] Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer". International Journal of Oncology 49, no. 2 (2016): 848-848. https://doi.org/10.3892/ijo.2016.3545